Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains

Epidemiology and Infection

Volumn 118, Issue 2, 1997, Pages 137-148

  Brett, P J ^a   Deshazer, D ^a   Woods, D E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ARTICLE; BACTERIUM ISOLATION; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; DNA SEQUENCE; GENE; GENE SEQUENCE; HAMSTER; NONHUMAN; PATHOGENESIS; PHENOTYPE;

ANIMALS; BASE SEQUENCE; BIOLOGICAL ASSAY; BURKHOLDERIA PSEUDOMALLEI; CRICETINAE; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; LETHAL DOSE 50; MESOCRICETUS; MOLECULAR SEQUENCE DATA; PHENOTYPE; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEROTYPING;

EID: 0030941091     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026889600739X     Document Type: Article

References (44)

1. Chaowagul W, White NJ, Dance DAB, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159: 890-9.
2. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11: 413-25.
3. Yabuchi E, Kosako, Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the group species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992; 36: 1251-75.
4. Howe C, Sampath A, Spotnitz M. The Pseudomallei group, a review. J Infect Dis 1971; 124: 598-606.
5. Redfearn MS, Palleroni NJ, Stanier RY. A comparative study of Pseudomonas pseudomallei and Bacillus mallei. J Gen Microbiol 1966; 43: 293-313.
6. Ellison DW, Baker HJ, Mariappan M. Melioidosis in Malaysia. I. A method for isolation of Pseudomonas pseudomallei from soil and surface water. Am J Trop Med Hyg 1969; 18: 694-7.
7. Leelarasamee A. Epidemiology of melioidosis. Infect Dis Antimicrob Agents 1986; 3: 84-93
8. Weinberg AN. Unusual bacterial pneumonias. In: Pennington JE, ed. Respiratory infections: diagnosis and management. 2nd ed. New York: Raven Press, 1989: 411-5.
9. Dance DAB, Davis TME, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989; 159: 654-60.
10. Sanford JP. Meliodiosis. In Mandell GL, Douglas RG, Bennet JE, eds. Practice and principles of infectious diseases. New York: Churchill Livingstone, 1985: 1250-4.
11. Smith CJ, Allen JC, Embi MN, Othman O, Ratzak N, Ismail G. Human melioidosis: an emerging medical problem. MIRCEN 1987; 3: 343-66.
12. Puthucheary SD, Parasakthi N, Lee MK. Septicemic melioidosis: a review of 50 cases from Malaysia. Trans Roy Soc Trop Med Hyg 1992; 86: 683-5.
13. Woods DE, Jones AL, Hill, PJ. Interaction of insulin with Pseudomonas pseudomallei. Infect Immun 1993; 61: 4045-50.
14. Esselmann MT, Liu PV. Lecithinase production by gram-negative bacteria. J Bacteriol 1961; 81: 939-45.
15. Heckly RJ, Nigg C. Toxins of Pseudomonas pseudomallei. II. Characterization. J Bacteriol 1958; 76: 427-36.
16. Heckly RJ, Nigg C. Differentiation of exotoxin and other biologically active substances of Pseudomonas pseudomallei filtrates. J Bacteriol 1964; 88: 1730-6.
17. Sexton MA, Chaowagul W, Woods DE. Purification and characterization of a protease from Pseudomonas pseudomallei. Cdn J Microbiol 1994; 40: 903-10.
18. Yang H, Chaowagul W, Sokol P. Siderophore production by Pseudomonas pseudomallei. Infect Immun 1991; 59: 776-80.
19. Yang H, Kooi CD, Sokol P. Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound. lactoferrin-bound and cell-derived iron. Infect Immun 1993; 61: 656-62.
20. Brett PJ, Mah CW, Woods DE. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun 1994; 62: 1914-9.
21. Steinmetz I, Rohde M, Brenneke B. Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect Immun 1995; 63: 3959-65.
22. Brett PJ, Woods DE. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun 1996; 64: 2824-8.
23. Bryan LE, Wong S, Woods DE, Dance DAB, Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis 1994; 5: 170-8.
24. Dannenberg Jr AM, Scott E. Melioidosis: pathogenesis and immunity in mice and hamsters. 11. Studies with avirulent strains of Malleomyces pseudomallei. Am J Pathol 1958; 34: 1099-121.
25. McCormick JB, Weaver RE, Hayes PS, Boyce JM, Feldman RA. Wound infection by an indigenous Pseudomonas pseudomallei-like organism isolated from the soil: case report and epidemiologic study. J Infect Dis 1977; 135: 103-7.
26. Miller WR, Pannell L, Cravitz L, Tanner WA, Rosebury T. Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. II. Virulence and infectivity for animals. J Bacteriol 1948; 55: 127-35.
27. Dannenberg Jr AM, Scott E. Melioidosis: pathogenesis and immunity in mice and hamsters. III. Effect of vaccination with avirulent strains of Pseudomonas pseudomallei on the resistance to the establishment and the resistance to the progress of respiratory melioidosis caused by virulent strains; all-or-none aspects of this disease. J Immunol 1959; 84: 233-46.
28. Ashdown LR. Identification of Pseudomonas pseudomallei in the clinical laboratory. J Clin Pathol 1979; 32: 500-4.
29. Schwyn B, Neilands JB. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987; 160: 47-56.
30. Gerhardt P, Murray RGE, Costilow RN, et al. Manual for methods in general bacteriology. Washington, D.C.: American Society for Microbiology, 1981.
31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
32. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979; 74: 4350-4.
33. Catty D, Raykundalia C. Antibodies. Vol I. Oxford: IRL Press, 1988; 164-7.
34. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1937; 27: 494-7.
35. Ausubel FM, Brent R, Kingston RE, et al, eds. Current protocols in molecular biology. New York: John Wiley and Sons Inc., 1988; 2.4.1-2.
36. Dharakul T, Songsivilai S, Viriyachitra S, Luangwedchakarn V, Tassaneetritap B, Chaowagul W. Detection of Burkholderia pseudomallei DNA in patients with septicemic melioidosis. J Clin Microbiol 1996; 34: 609-14.
37. Floro G, Buzzelli JA, Griffin W, Stolz JF. Unpublished data, 1994. GenBank accession number U16140.
38. Mueller JG, Devereux R, Santavy DL, Lantz SE, Willis SG, Pritchard PH. Unpublished data, 1995. GenBank accession numbers U37340, U37342, U37343 and U37344.
39. Dance DAB, Wuthrokanun V, Naigowit P, White NJ. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol 1989; 42: 645-8.
40. Dannenberg Jr AM, Scott E. Melioidosis: pathogenesis and immunity in mice and hamsters. I. Studies with virulent strains of Malleomyces pseudomallei. J Exp Med 1957; 107: 153-87.
41. Ashdown LR, Koehler JM. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J Clin Microbiol 1990; 28: 2331-4.
42. Nigg C, Heckly RJ, Colling M. Toxin produced by Malleomyces pseudomallei. Proc Soc Exp Biol Med 1955; 89: 17-20.
43. Finegold MJ. Pathogenesis of plague: a review of plague deaths in the United States during the last decade. Am J Med 1968; 45: 549-54.
44. Gleiser CA. Pathology of anthrax infection in animal hosts. Fed Proc 1967; 26: 1518-21.